Delivery Order SPE2DB20D3101-SPE2DB24FRRV8
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor to the U.S. federal government. The $2,704.32 firm fixed-price contract is for the supply of TWINRIX VACCINE SYRINGES, a hepatitis A and hepatitis B combination vaccine, with a completion date of September 4, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $100,636.46, is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $14,477.01, is for the supply of the TWINRIX vaccine, a combination hepatitis A and hepatitis B vaccine, to support federal healthcare programs. The Firm Fixed Price contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B combination vaccine, with a ceiling value of $5,728.81. The contract is a firm fixed-price delivery order with a performance period extending to June 13, 2025. This contract is not designated as a set-aside, indicating open...
This federal contract award, valued at $13,656.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX vaccine syringes, a vaccine for Hepatitis A and Hepatitis B. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of August 28, 2024. It is not designated as a Set-Aside contract, indicating open...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the TWINRIX VACCINE SYRINGE, a combination hepatitis A and hepatitis B vaccine, with a ceiling value of $3,639.25 and a period of performance through May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,818.87 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract has an ultimate completion date of March 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,050.76 firm fixed-price contract is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine, to support defense medical requirements. The contract has a completion date of June 4, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This is a $78,639.88 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the TWINRIX VACCINE SYRINGE, a hepatitis A and hepatitis B vaccine. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the TWINRIX Vaccine, a hepatitis A and hepatitis B combination vaccine, in syringes. The contract is a firm fixed-price Delivery Order with a ceiling value of $1,248.05 and an ultimate completion date of May 30, 2025. The award does not utilize a set-aside designation, indicating open...